Campylobacteriosis is a zoonosis that can be transmitted directly or indirectly between animals and humans leading to intestinal infections. Eating undercooked chicken, or ready-to-eat foods that have been in contact with raw chicken, is the most common source of the infection (20-30%). There are currently 25 species in the Campylobacter genus; however Campylobacter jejuni and C. coli are the two principal causes of human gastroenteritis worldwide. Though death from campylobacteriosis is rare, risk of complications in risk groups is high namely in the young and elderly, and those with concurrent chronic disease and immunocompromised status. Campylobacteriosis affects the digestive system, causing diarrhoea, abdominal pain, malaise, fever, nausea and vomiting. The costs based on the incidence, prevention and control of campylobacteriosis are high with critical impacts on surveillance programmes and hence the costs and benefits must be carefully considered. Bacteriophages have been discussed worldwide as a therapeutic tool to control and prevent Campylobacter. Another promising strategy is the addition of lactic acid bacteria and/or bacteriocins in the feed to mnimise/control Campylobacter in poultry. Antibiotic treatment is a control strategy but several authors have been describing the occurrence of multidrug resistance profiles among Campylobacter strains. There is now a strong movement against the use of antibiotics in food production. In addition, several "Model Food Codes" (proper sanitation and cooking procedures) are described in order to prevent crosscontamination, which can subsequently decrease the risk of Campylobacter infection.
Campylobacter and Campylobacteriosis -an Overview
Campylobacter genus typically comprises of microaerophilic spiral-shaped Gram-negative cells. Growth under aerobic and anaerobic conditions has also been reported; they require relatively high temperatures (Silva et al., 2011) . Campylobacter is the organism responsible for campylobacteriosis in humans. About 200,000 human cases are reported every year and this disease is still the most frequently reported foodborne illness in the Europe Union (EU). Recently, European Food Safety
Campylobacter in food
Campylobacter spp. are often found in contaminated food products representing a risk of zoonotic transmission to humans; consumption of contaminated, unpasteurized animal milk and milk products, undercooked poultry and contaminated drinking water is well recognized as a vehicle of infection (EFSA, 2014b; Sarkar et al., 2014) . Poultry are natural and asymptomatic carriers of C. jejuni and C. coli responsible for up to 80% of the human Campylobacter infections (Wagenaar et al., 2013) . According to these authors, it is estimated that in the EU, 30% of the human infections are associated with consumption and preparation of poultry meat. Campylobacter spp. can be present in various foodstuffs including meat, raw milk and dairy products and less frequently in fish and fishery products, mussels and fresh vegetables (EFSA, 2014a) .
According to Andrzejewska et al. (2015) , the occurrence of Campylobacter spp. in poultry meat from Northern Poland is 41.6% with higher incidence of C. jejuni. In Estonia, the prevalence and counts of Campylobacter spp. in poultry meat at retail level was shown to be 20.8% and 3.20 log10 CFU/g (mean number of campylobacters in fresh broiler chicken meat) (Mäe saara et al., 2014) . In Latvia the occurrence of Campylobacter spp. in broiler chicken production at slaughterhouse and retail level was determined and it was reported that 92.5%, 60.8% and 56.3% of the pooled intestine samples, the neck skin samples and of carcasses were positive for Campylobacter spp., respectively (Kovalenkoa et al., 2014) . According to these authors, a seasonal variation was observed in proportions of Campylobacter positive samples, with a seasonal peak in summer months. A total of 471 duck and goose intestinal contents were analysed by Jamalia and collaborators (Jamalia et al., 2015) ; 39.2% of duck and 26.1% of goose samples were positive for Campylobacter spp. The isolates were mainly C. jejuni (85.7%) and C. coli (14.3%). Fresh or minimally processed vegetables can be contaminated before harvest or throughout handling. The survival of C. jejuni strains on spinach under different conditions was evaluated (Guévremont et al., 2015) . Strains of this species from different animal or environmental origins were able to survive on spinach; this survival was dependent on the storage parameters and bacterial strain. According to these authors, fresh spinach with a significant contamination can represent a threat to human health.
Campylobacter in animals
Poultry and poultry products are considered to be the largest contributors of human Campylobacter infection, 50-70% estimated. Poultry includes broilers, laying hens, turkeys, ducks, and ostriches (Sharon et al., 2013) . Contact with contaminated poultry, livestock or household pets, especially puppies, can also cause the disease (Sarkar et al., 2014) . In fact, Campylobacter spp. colonize a wide range of hosts including pets, farm animals and wild animals. Primarily, Campylobacter is found in broiler flocks (reported prevalence varies between the EU member states, but high prevalence (63.4%) and extremely high (83.6%) have already been reported) but also in pigs, cattle, goats, sheep and pets (EFSA, 2014a). Little information is available concerning the role of Campylobacter spp. in large game species; Campylobacter spp. strains associated with human campylobacteriosis were infrequently detected in 33 hunting estates during two hunting seasons, indicating a limited zoonotic risk in the studied area (Dí az-Sánchez et al., 2013) . The Despite the high numbers of campylobacteriosis cases, outbreaks caused by this agent are uncommon compared with sporadic cases (Little et al., 2010; Taylor et al., 2013; Revez et al., 2014) . The outbreaks have historically differed from sporadic cases inseasonality and contamination source. According to Taylor and his collaborators (2013) , in the USA, from 1997 to 2008, 262 outbreaks were reported, with 9,135 illnesses, 159 hospitalizations, and three deaths. According to these authors, poultry and dairy products are the most common vehicles identified for outbreaks, namely 11 and 29%, respectively. Historically, few foods have been recalled due to the presence of Campylobacter spp. (Table 1) , whereas contaminated drinking water and unpasteurized raw milk have occasionally been recalled due to Campylobacter contamination (Taylor et al., 2013; Revez et al., 2014) . During 1998-2008, CDC received reports of 13,405 foodborne disease outbreaks, eight pathogens caused 89% of the 5,059 confirmed, single-etiology outbreaks, 2% caused by C. jejuni (Gould et al., 2013) . In the UK, from 1992 to 2009, 114 foodborne outbreaks of campylobacteriosis were reported to the Health Protection Agency; 64% occurred in food service establishments. Poultry meat was the most commonly reported vehicle of infection (38%) (Little et al., 2010) . According to this study, since 2007, the number of outbreaks of campylobacteriosis linked to consumption of poultry liver pâté in England and Wales significantly increased (from 12% to 74%) with a higher frequency in December. persons. Transmission was predominantly foodborne or suspected foodborne (82%), 30% of the foodborne outbreaks were attributed to food prepared or eaten at institutions; 15% at aged care facilities and 11% at school camps. Poultry (chicken or duck), waterborne, unpasteurized milk and salads were associated with the reported outbreaks. According to these authors, outbreaks continue to constitute a very small proportion of notifications since improved recognition through subtyping is required. Parry et al. (2012) reported an outbreak of campylobacteriosis associated with chicken liver pâté at a surprise birthday party; outbreaks of this kind may be greatly underestimated since Campylobacter isolates are not routinely subtyped and the identification of outbreaks is largely restricted to temporal or geographical associations or reliance on medical notifications identifying common events. According to (EFSA, 2014a) , half of the Campylobacter outbreaks have been related with broiler meat and raw milk. In addition, from 2008 to 2012 a clear seasonal trend was observed in Europe. In 2012, 31 deaths due to campylobacteriosis were reported (in 14 member states); 20 of those deaths were in the United Kingdom. Campylobacter jejuni and C. coli were responsible for 81.1 and 6.2% of the cases, respectively. Globally, defining the scope of a given outbreak, identifying the source of the strains and tracing the route by which the bacteria infect the humans are crucial parameters that should be considered.
Antibiotic Resistance -the Need for Alternative Controls
Historically antibiotics have been used in livestock farming both for the treatment of infections and as growth promoters. However the practice of administering growth promoters containing antimicrobials has been gradually banned in Europe (2013).
The frequent use of antibiotics in the veterinary field, has been contributing to the increased trend in the resistance of Campylobacter strains (and also in other foodborne pathogens) isolated from man and poultry, especially to fluoroquinolones and macrolides (Endtz et al., 1991; Nachamkin et al., 2002; Wieczorek and Osek, 2013) . In fact, resistant and particularly multiresistant Campylobacter strains are being alarmingly spread, representing an increasing phenomenon that demands enforced interventions at multidisciplinary levels and is one of the challenges of campylobacteriosis control, worldwide (Wimalarathna et al., 2013; Carmelo et al., 2013; EFSA, 2014b) . In the European Union, antimicrobial resistance is commonly detected in Campylobacter isolated from human cases as well as from food-producing animals and food (EFSA, 2014b) . According to the last summary report disseminated by EFSA (2014b), a high resistance level to ampicillin, ciprofloxacin, nalidixic acid and tetracycline among Campylobacter isolates from human cases was reported by the member states, while resistance to erythromycin was low to moderate. The resistance trend for C. jejuni isolates was for ciprofloxacin (54.1%) and for nalidixic acid 53.3%. Among C. coli isolates, 69% were reported resistant to nalidixic acid and ciprofloxacin, followed by tetracyclines 49.7% and ampicillin 36.0%. Concerning isolates of C. jejuni and C. coli, the levels of resistance to erythromycin is overall low and moderately high, respectively. In addition, one in six human C. coli isolates were resistant to both erythromycin and ciprofloxacin. These two antibiotics are commonly administrated for treatment of campylobacteriosis emphasizing the problem related with combined resistance (coresistance) to critically important antimicrobials (EFSA, 2014b). However, according to EFSA, coresistance to critically important antimicrobials remains low (EFSA, 2014b).
Concerning Campylobacter isolates from food samples, namely fowl, broiler meat, pigs and cattle, high to extremely high resistance to ciprofloxacin, nalidixic acid and tetracyclines and low resistance levels for erythromycin and gentamicin were recorded (EFSA, 2014b): 59.5%, 57.9% and 47.5% of strains of C. jejuni isolated from meat and broilers, were resistant to ciprofloxacin, nalidixic acid and tetracycline, respectively. For C. coli, the percentages of strains resistant to these three antibiotics was of 82.7%, 81% and 57.3%, respectively (EFSA, 2014b) . Overall, C. coli presented a higher resistance trend compared to C. jejuni, for both human and food strains. Griggs et al. (2005) reported quinolone-resistant Campylobacter strains in commercial chicken flocks that were treated with veterinary fluoroquinolone; 53% of the C. jejuni and 82% of C. coli were ciprofloxacin resistant. In addition, these authors reported that quinolone-resistant Campylobacter strains were present in the faeces of some flocks up to the point of slaughter, thereby presenting a potential public health problem. According to Hart et al. (2004) , Campylobacter strains isolated from pigs are mainly ciprofloxacin-susceptible, since in Australia the application of fluoroquinolones in animal production is prohibited. A significantly higher prevalence of Campylobacter isolates resistant to ciprofloxacin was reported by Maćkiwa et al. (2012) , 97.9%. Moreover, 7.0% of the isolates were found to be resistant to at least three unrelated antibiotics. According to Abay et al. (2014) , erythromycin, amoxicillin, clavulanic acid and gentamicin are recommended for the treatment of Campylobacteriosis in humans since most of the C. jejuni isolated from poultry and humans in T.urkey were sensitive to these antibiotics. Wimalarathna et al. (2013) reported that 38.02% of C. jejuni and C. coli isolates were resistant to tetracycline and 22.26% to quinolones. Concerning erythromycin and chloramphenicol, low resistance levels were observed, 4.59% and 2.59%, respectively. Jamalia et al. (2015) reported that Campylobacter isolates collected from ducks and geese were resistance to ciprofloxacin, tetracycline and nalidixic acid; among those strains, 60.2% were multidrug resistant.
In Portugal, a high resistance rate was reported for quinolones (n = 196 Campylobacter strains; 100% to nalidixic acid and > 90% to ciprofloxacin) and, in general, resistance was more common among C. coli, especially for erythromycin (40.2% vs. 6.7%; Duarte et al., 2014) . According to these authors, most isolates (86%) were resistant to multiple antimicrobial families.
Campylobacter and Biocontrol

Bacteriophages
The widespread acquisition of antimicrobial resistance among Campylobacter isolates has been a matter of concern and the elimination of antibiotics as growth promoters in livestock is being actively examined (Ganan et al., 2012) . Thereby, new, natural and sustainable strategies have been reported in the literature in order to reduce the incidence of this bacterium in the food chain, especially in its main host. One particular strategy is the use of bacteriophages, viruses that can only lyse targeted bacterial cells (Loc-Carrillo et al., 2011) . The specificity of phages to the target bacteria is well known; once the phage attaches to the host cell, its DNA is ejected into the cell and takes over the host's DNA replication, transcription and translation processes to produce progeny phages. On lysis of the producing cells, 'new' phages are then capable of infecting other target cells nearby. This specificity and effectiveness prevents dysbiosis which means that the normal flora is not affected (Guttman et al., 2005) . According to Garcí a et al. (2008) , phages can be used to combat pathogens in food at all stages of production in the classic 'farm-to-fork' continuum in the human food chain. Phages for use as therapeutic or biocontrol agents on pathogenic bacteria such as Campylobacter, must meet a few criteria namely i) they must be obligatorily lytic and therefore only capable of infecting bacterial cells and producing progeny phage without the capacity to integrate into the bacterial genome or transduce bacterial genes from one cell to another (Canchaya et al., 2003) and ii) possess physical characteristics that will facilitate their survival in the environments to which they will be applied (Loc-Carrillo et al., 2011; Carvalho et al., 2012b) .
In 2005, Wagenaar et al. reported that phage therapy is a promising alternative for reducing C. jejuni colonization in broilers, either as a preventive or a therapeutic measure. According to the results obtained, these authors suggested that the phage treatment did not prevent the colonization of the caecum, but may delay it; an initial reduction of Campylobacter by 2 log10 CFU/g was observed and one week after the numbers reached out at approximately 1 log10 compared with the control (no phage administered to the chicks). In the study conducted by Loc Carrillo et al. (2011) , chickens were treated with two Campylobacter phages, CP8 and CP34. The results varied within the tested phage and according to the dose administered to the chicken; CP8 was shown to have the higher efficacy for reducing Campylobacter in the chicken caecum (> 5 log10 CFU/g). Later, El-Shibiny et al. (2009) reported that a single 107 or 109 PFU (plaque forming units) dose of CP220 resulted in a 2 log10 CFU/g reduction in Campylobacter counts that colonized chickens; after treatment, only 2% of the recovered Campylobacter displayed resistance to CP220. More recently, Carvalho et al. (2010) studied the efficacy of a phage cocktail composed of three phages for the control of poultry infected with C. coli and C. jejuni; the phage cocktail was able to reduce by approximately 2 log10 CFU/g the titre of both C. coli and C. jejuni in faeces of colonized chickens.
These authors also tested the administration of phages in feed to Campylobacter-infected chicks and concluded that administering phages to poultry via the food could be successful on a commercial scale (faster reduction). Campylobacter phages have been isolated from several sources namely sewage, pig and poultry manure, abattoir effluents, broiler chickens and retail poultry. After the isolating step, phages have been characterized and special attention has been given to the lytic spectrum of each phage or a given mixture of phages. Globally, the sensitivity to individual bacteriophages varies according to the strain and specie (Bigwood et al., 2008; Carvalho et al., 2009; El-Shibiny et al., 2009; Loc-Carrillo et al., 2011; Carvalho et al., 2012b; Owens et al., 2013) . To date, six Campylobacter phage sequences have been published and are available in EMBL and GeneBank (Timms et al., 2010; Kropinski et al., 2011; Carvalho et al., 2012a; Hammerl et al., 2012) . The development of phage-resistant mutants has already been reported as potentially a contra-indication in the application of phages [42] ; however further research is still needed to answer which type of resistance is actually relevant for phage therapy and other phage applications (Loc-Carrillo et al., 2011) . Phage-based products against Campylobacter are not on the market but a few companies have publically declared interest in developing such products including Intralytix, GangaGen and Micreos (Loc-Carrillo et al., 2011).
Probiotics and bacteriocins
Alternative practices to biocontrol Campylobacter spp. in broiler feed are currently being investigated namely probiotics (Gaggia et al., 2010) and bacteriocins (Svetoch and Stern, 2010) . However limited information is available regarding their effects in poultry namely in poultry nutrition and/or microbiology (Józefiak and Sip, 2013) . Bacteriocins have either bactericidal or bacteriostatic activity and are known as antimicrobials that do not disturb the global ecosystem. Lactic acid bacteria and bacteriocins are generally recognized as safe (GRAS; so far there has been no information about negative effects on animals or humans) and their industrial interest has been increasing. However two limitations are recognized: i) the spectrum of activity of most LAB bacteriocins is rather narrow and may not inhibit the variety of microorganisms found in foods; ii) less activity against Gram-negative bacteria and iii) bacteriocin resistance. Strains producing bacteriocins are commonly spread among genera of Lactobacillus, Lactococcus, Pediococcus, Carnobacterium, Enterococcus, Escherichia, Bacillus, Paenibacillus, Staphylococcus, Pseudomonas, Clostridium, and others (Svetoch and Stern, 2010) . Bacteriocins are divided into 3 classes and classes I and II are the best studied and have practical application. Cole and his collaborators (Cole et al., 2006) reported that bacteriocins produced by Bacillus circulans and Paenibacillus polymyxa reduce caecal Campylobacter colonization in broiler chickens infected with C. jejuni. Bacteriocins, with antimicrobial activity against C. jejuni, were reported to be present in broiler chicken excreta (Nazef et al., 2008; Belguesmia et al., 2011) .
In 2008, Stern et al. (2008) studied the effect of adding probiotic strains to chicken feed as a prophylactic probiotic treatment. These authors reported that probiotic strains were effectively reduced C. jejuni colonization only when very low challenge levels of C. jejuni were used. Two of those probiotic strains were selected, Lactobacillus salivarius NRRL B-30514 and Paenibacillus polymyxa NRRL B-30509, and further studied for efficacy in reducing C. jejuni in chickens. Purified bacteriocins/kg feed were fed therapeutically to chickens and colonization by C. jejuni was reduced by at least one million-fold. However, treatments with viable probiotic bacterial cultures were ineffective in reducing C. jejuni in chickens.
Bacteriocin treatments can reduce poultry colonization of Campylobacter from > 10 8 cfu/g of caecal materials to non-detectable or very low levels in treated birds (Svetoch and Stern, 2010) . Connerton et al. (2011) also verified that feeding broilers with bacteriocins reduced Campylobacter to non-detectable levels. According to the work reported by Messaoudi et al. (2012) , L. salivarius SMXD51, previously isolated from chicken caeca, produces a component that inhibits the growth of C. jejuni (bacteriocin SMXD51) that has potential to reduce Campylobacter in poultry prior to processing.
Other alternatives for the control of Campylobacter
Natural products from plants present good alternatives to be used in foods or as therapeutic agents in order to prevent/control Campylobacter spp. (2011). These authors tested 28 edible or medicinal plant species for their bactericidal effects on the growth of C. jejuni and C. coli. Acacia farnesiana, Artemisia ludoviciana, Opuntia ficus-indica, and Cynara scolymus extracts were the most effective against Campylobacter; adherence and cytotoxic activity of the bacteria to host mucosal surfaces was decreased by these extracts. In fact, plants are potential candidates for the control of Campylobacter contamination in foods, the treatment of the diseases associated with this microorganism, and as feed supplements to reduce on-farm prevalence of Campylobacter (Castillo et al., 2011) .
The anti-Campylobacter effect of natural phenolic compounds extracted from plants has also been described by Klancˇnik and his collaborators, 2012 . These authors emphasized the high Joana Silva and Paula Teixeira / American Journal of Advanced Food Science and Technology (2015) Vol. 3 No. 2 pp. 107-124 116 potential of these agents. Salaheen and his collaborators (2014) tested the effect of the bioactive components from blueberry and blackberry pomaces on C. jejuni growth and pathogenicity. Blackberry and blueberry pomace extracts significantly reduced the growth of C. jejuni by altering some of the physicochemical properties such as the cell surface hydrophobicity and auto-aggregation of this bacterial pathogen. In addition, swimming and swarming motility of C. jejuni were significantly reduced as well as the expression of the virulence genes and their interactions with host cultured cells.
Solis de los reported that therapeutic supplementation of caprylic acid in the feed can effectively decrease Campylobacter in market-aged chickens and may be a potential treatment for decreasing pathogen carriage in poultry. Recently, Arsi et al. (2014) reported the efficacy of natural plant extracts such as thymol and carvacrol against Campylobacter colonization in broiler chickens. They observed that feed supplementation with these compounds reduced Campylobacter colonization in chickens.
The 
Preventing Campylobacter and Good Practices
To prevent Campylobacter infections, it is important to follow basic food hygiene practices when preparing food. In fact, improving culinary and catering practices are important procedures f o r 2009; Zeng et al., 2010) . Zeng et al. (2010) developed a novel vaccine against C. jejuniCmeC Subunit Vaccine reducing exposure to Campylobacter-contaminated products (Newell et al., 2011) . According to these authors, from 1992 to 2009, 114 general foodborne outbreaks of campylobacteriosis were reported to the Health Protection Agency, most occurring in food service establishments (64%). Some food handling practices that can prevent Campylobacter infections include the following:
-Cook all types of poultry products properly; all poultry should be cooked to reach a minimum internal temperature of 74 ºC; -Wash hands frequently when preparing food especially after handling raw foods from animal origin; -Prevent cross contamination i.e. using separate cutting boards for foods of animal origin and other foods and by thoroughly cleaning all cutting boards, countertops, and utensils with soap and hot water after preparing raw food of animal origin; -Do not drink unpasteurized milk or untreated surface water; -Make sure that people with diarrhea, especially children, wash their hands carefully and frequently to reduce the risk of spreading the infection; -Wash hands with soap and hot water after contact with pet faeces.
On the other hand, to prevent Campylobacter from being transmitted to a poultry flock (primary production), biosecurity implementations are required, namely use of modern housing that is well maintained and with limited access, boot dips, and fly screens (Newell et al., 2011) . These authors also reported that complimentary non-biosecurity measures are relevant to reduce the risk of flock infection such us thoroughness of cleaning and disinfecting the poultry house between flocks. Some of these measures are concerned with appropriately treated water for drinking, reducing slaughter age and discontinuing thinning (Zeng et al., 2010) . According to Guerin et al. (2010) , chilling, washing, defeathering, scalding and evisceration have shown a limited effect at reducing the presence of Campylobacter. Post-slaughter irradiation or cooking on an industrial scale can reduce the risk by 100%. Freezing the carcasses for 2-3 weeks can reduce the risk by > 90%, whereas freezing for 2-3 days will reduce the risk between 50 and 90%; these results are similar to carcass decontamination using hot water, lactic acid, acidified sodium chlorite or trisodium phosphate (EFSA, 2011; Meredith et al., 2013) .
The Cost of Campylobacteriosis
EFSA claims that the cost of campylobacteriosis to public health systems and to lost productivity in the EU is estimated to be around EUR 2.4 billion a year (EFSA, 2014a). In the United States, Campylobacter is reported to be the third most prevalent bacterial pathogen with an estimated annual cost of illness to be $1.7 billion (Jensen et al., 2015) . In Europe campylobacteriosis is the most common foodborne bacterial illness and estimates of the true incidence rate for Campylobacter-associated infections is 9.2 million, with a total annual cost of €2.4 billion (Meredith et al., 2013) .
According to Jensen et al. (2015) , using a system-wide policy approach to reduce the risk of campylobacteriosis can be more cost-effective than a policy focusing purely on farm-level interventions. In addition, according to these authors, allowing for chemical decontamination methods may enhance cost-effectiveness of intervention strategies further. Wagenaar and collaborators (2013) commented that interventions in the poultry meat production chain have not been effectively introduced and a multilevel approach should be followed, aiming at reducing the level of contamination of consumer products rather than complete absence of Campylobacter.
Conclusion
The actual incidence rate of gastroenteritis due to Campylobacter spp. is poorly known and frequently under-reported, and several approaches are being used to estimate it. Worldwide, Campylobacter is considered to be the most frequently occurring bacterial agent of gastroenteritis. In order to control/reduce this contaminant, several promising biocontrol approaches can be considered, namely the addition of LAB such as probiotics, bacteriocins and/or bacteriophages. These suggestions are in alignment with the EFSA report and should be considered as therapeutic tools to control and prevent Campylobacter.
